Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
5189.20Today’s High
5316.8052W low
3447.0052W High
5578.80Open Price
5210.00Prev. Close
4854.6000Volume
171984.00Value
909769562.40Fundamentals
Market Cap
63248.10
Price to Earnings
35.20
Price to Book Value
5.90
Dividend Yield
0.90
PE to Growth
0.40
Op Revenue TTM
12667.58
Net Profit TTM
1795.77
Cash From Operating Activity
1948.08
Return on Equity %
17.41
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
26 Jul, 2024
68
Week
57.3
Month
60.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
5265.32
PIVOT
First Resistance
5341.38
Second Resistance
5392.92
Third Resistance
5468.98
First Support
5213.78
Second Support
5137.72
Third Support
5086.18
Relative Strength Index
57.22
Money Flow Index
55.74
MACD
42.54
MACD Signal
41
Average True Range
142.34
Average Directional Index
14.82
Rate of Change (21)
6.36
Rate of Change (125)
9.85
Commodity Channel Index
67.5
Williams %R
-38.2
BETA
1 Month
0.9
3 Month
0.6
1 Year
0.52
3 Year
0.13
PRICE CHANGE ANALYSIS
↑ 3.04%
1 Week
Low
High
5030.4
5316.85
↑ 7.44%
1 Month
Low
High
4872
5450
↑ 7.73%
3 Months
Low
High
4407.05
5578.8
↑ 6.4%
6 Months
Low
High
4407.05
5578.8
↑ 31.32%
1 Year
Low
High
3447
5578.8
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 2449.16 | 2590.25 | 2696.43 | 2317.87 | 2314.59 | 2357.46 | 2535.13 | 2113.66 | 2060.54 | 2244.08 | 2407.20 | 2317.88 | 1966.24 | |
| Operating Expenses Qtr | 1957.85 | 1925.33 | 1979.99 | 1919.42 | 1906.00 | 1840.75 | 2055.81 | 1875.04 | 1806.62 | 1708.58 | 1776.15 | 1728.10 | 1501.06 | |
| Operating Profit Qtr | 407.52 | 569.26 | 654.60 | 333.75 | 331.99 | 455.97 | 405.68 | 183.31 | 199.69 | 472.26 | 587.84 | 550.57 | 416.41 | |
| EBIDT Qtr Cr | 478.79 | 613.61 | 716.44 | 398.45 | 408.59 | 516.71 | 479.32 | 238.62 | 253.92 | 535.50 | 631.05 | 589.78 | 452.40 | |
| Depreciation Qtr | 69.10 | 58.12 | 59.02 | 58.11 | 57.16 | 58.14 | 57.74 | 56.81 | 55.01 | 58.43 | 53.82 | 51.72 | 49.38 | |
| Net Profit Qtr | 324.97 | 504.23 | 646.51 | 271.44 | 254.79 | 388.89 | 350.69 | 140.10 | 76.88 | 437.09 | 558.01 | 469.27 | 362.74 | |
| Basic EPS Qtr | 27.18 | 42.17 | 54.07 | 22.70 | 21.31 | 32.53 | 29.33 | 11.72 | 6.43 | 36.56 | 46.67 | 39.25 | 30.34 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 10053.71 | 9320.84 | 9029.70 | 7409.69 | 6773.06 | |
| Operating Expenses Annual Cr | 7782.59 | 7677.60 | 7019.45 | 5270.75 | 5209.43 | |
| Operating Profit Annual | 1965.13 | 1376.95 | 1810.36 | 1948.93 | 1467.65 | |
| Operating Profit Margin Annual % | 19.55 | 14.77 | 20.05 | 26.30 | 21.67 | |
| Total Expenses Annual Cr | 8108.85 | 7993.85 | 7276.33 | 5512.61 | 5434.98 | |
| EBIDT Annual Cr | 2271.12 | 1643.24 | 2010.25 | 2138.94 | 1563.63 | |
| EBIDT Annual margin % | 22.59 | 17.63 | 22.26 | 28.87 | 23.09 | |
| Depreciation | 244.35 | 229.85 | 218.98 | 198.93 | 186.84 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1747.15 | 1134.47 | 1541.25 | 1685.08 | 1264.42 | |
| Net Profit Annual | 1747.15 | 1134.47 | 1541.25 | 1685.08 | 1264.42 | |
| Basic EPS Annual | 146.13 | 94.88 | 128.90 | 140.93 | 105.75 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 10554.61 | 9349.85 | 8743.66 | 7625.75 | 6280.44 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 376.79 | 336.54 | 301.75 | 237.04 | 245.63 | |
| Total Current Liabilities Annual Cr | 3106.40 | 3044.83 | 4123.76 | 2909.94 | 2579.76 | |
| Total Capital Plus Liabilities Annual Cr | 14037.80 | 12731.22 | 13169.17 | 10772.73 | 9105.83 | |
| Fixed Assets Annual | 1873.02 | 2053.84 | 2114.52 | 2081.62 | 2150.42 | |
| Total Non Current Assets Annual | 5997.72 | 5959.01 | 6308.56 | 5141.19 | 4876.65 | |
| Total Current Assets Annual | 8040.08 | 6772.21 | 6860.61 | 5631.54 | 4229.18 | |
| Total Assets Annual | 14037.80 | 12731.22 | 13169.17 | 10772.73 | 9105.83 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 314.71 | 359.22 | 376.65 | 329.70 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1686.56 | 1437.42 | 1299.34 | 1324.48 | 681.78 | |
| Cash from Investing Activity Annual | -865.61 | 197.04 | -1669.33 | -1120.99 | -995.17 | |
| Cash from Financing Annual Activity | -959.04 | -1711.27 | 436.59 | -208.96 | 172.64 | |
| Net Cash Flow Annual | -138.09 | -76.81 | 66.60 | -5.47 | -140.75 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 882.86 | 782.09 | 731.38 | 637.87 | 525.34 | |
| ROE Annual % | 16.55 | 12.13 | 17.62 | 22.09 | 20.13 | |
| ROCE Annual % | 18.54 | 14.59 | 19.80 | 24.67 | 21.09 | |
| Total Debt to Total Equity Annual | 0.09 | 0.12 | 0.26 | 0.18 | 0.19 | |
| EBDIT Annual Margin % | 23.29 | 18.14 | 22.76 | 29.62 | 23.41 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 3023.99 | 3417.51 | 3503.36 | 3033.56 | 2971.27 | 3086.24 | 3130.04 | 2627.79 | 2504.38 | 2672.50 | 2841.95 | 2778.01 | 2238.44 | |
| Operating Expenses Qtr | 2533.84 | 2616.28 | 2693.44 | 2578.53 | 2549.35 | 2441.86 | 2625.46 | 2373.14 | 2146.63 | 2120.53 | 2175.61 | 2138.50 | 1901.06 | |
| Operating Profit Qtr | 401.98 | 707.59 | 746.73 | 389.19 | 353.25 | 599.05 | 453.91 | 203.24 | 337.23 | 498.45 | 624.38 | 592.86 | 291.10 | |
| EBIDT Qtr Cr | 477.63 | 749.92 | 752.26 | 455.03 | 318.94 | 644.38 | 504.58 | 254.65 | 342.79 | 551.97 | 666.34 | 639.51 | 337.38 | |
| Depreciation Qtr | 83.43 | 69.56 | 73.90 | 72.41 | 78.32 | 78.44 | 77.40 | 76.26 | 83.14 | 77.46 | 72.83 | 70.53 | 68.51 | |
| Net Profit Qtr | 293.56 | 594.96 | 620.52 | 286.73 | 70.98 | 454.71 | 330.84 | 127.64 | 107.58 | 525.66 | 544.26 | 468.12 | 239.99 | |
| Basic EPS Qtr | 24.55 | 49.76 | 51.90 | 23.98 | 5.94 | 38.03 | 27.67 | 10.68 | 9.00 | 43.96 | 45.52 | 39.15 | 20.07 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 12978.42 | 11815.34 | 10796.84 | 9098.22 | 8448.58 | |
| Operating Expenses Annual Cr | 10422.09 | 9989.81 | 8581.27 | 6922.62 | 6870.97 | |
| Operating Profit Annual | 2245.49 | 1609.45 | 2052.92 | 1942.39 | 1473.39 | |
| Operating Profit Margin Annual % | 17.30 | 13.62 | 19.01 | 21.35 | 17.44 | |
| Total Expenses Annual Cr | 10833.80 | 10407.59 | 8937.60 | 7256.12 | 7188.79 | |
| EBIDT Annual Cr | 2556.33 | 1825.53 | 2215.57 | 2175.60 | 1577.61 | |
| EBIDT Annual margin % | 19.70 | 15.45 | 20.52 | 23.91 | 18.67 | |
| Depreciation | 299.30 | 310.42 | 303.96 | 274.58 | 252.76 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1811.46 | 1006.81 | 1680.32 | 1617.77 | 1149.31 | |
| Net Profit Annual | 1795.77 | 984.17 | 1645.62 | 1585.02 | 1127.07 | |
| Basic EPS Annual | 150.19 | 82.31 | 137.63 | 132.57 | 94.26 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 10312.06 | 9045.29 | 8637.90 | 7376.73 | 6160.67 | |
| Minority Interest Liability Annual Cr | 402.34 | 389.71 | 209.43 | 181.28 | 148.30 | |
| Total Non Current Liabilities Annual Cr | 865.95 | 614.50 | 416.52 | 357.20 | 391.99 | |
| Total Current Liabilities Annual Cr | 3994.55 | 3707.15 | 4805.34 | 3604.05 | 3244.58 | |
| Total Capital Plus Liabilities Annual Cr | 15574.90 | 13756.65 | 14069.19 | 11519.26 | 9945.54 | |
| Fixed Assets Annual | 2614.61 | 2592.90 | 2838.12 | 2790.87 | 2872.53 | |
| Total Non Current Assets Annual | 5163.32 | 5026.95 | 5633.76 | 4590.44 | 4439.89 | |
| Total Current Assets Annual | 10411.58 | 8729.70 | 8435.43 | 6928.82 | 5505.65 | |
| Total Assets Annual | 15574.90 | 13756.65 | 14069.19 | 11519.26 | 9945.54 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 410.26 | 425.90 | 449.06 | 357.59 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1948.08 | 1682.50 | 1111.02 | 1264.90 | 585.08 | |
| Cash from Investing Activity Annual | -1008.51 | 112.84 | -1435.13 | -998.54 | -741.35 | |
| Cash from Financing Annual Activity | -1145.01 | -1760.82 | 379.57 | -271.75 | 79.15 | |
| Net Cash Flow Annual | -205.44 | 34.52 | 55.46 | -5.39 | -77.12 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 896.23 | 789.21 | 740.05 | 632.20 | 527.73 | |
| ROE Annual % | 17.41 | 10.88 | 19.05 | 21.48 | 18.29 | |
| ROCE Annual % | 19.49 | 15.07 | 20.63 | 24.01 | 19.77 | |
| Total Debt to Total Equity Annual | 0.12 | 0.14 | 0.30 | 0.23 | 0.26 | |
| EBDIT Annual Margin % | 20.18 | 15.73 | 20.83 | 24.54 | 18.90 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Icici Prudential India Opportunities Fund | 4.22 | 88544182 | - | - |
| Kotak Emerging Equity Scheme | 1.06 | 88544186 | - | - |
| Hdfc Life Insurance Company Limited | 1.45 | 88544188 | - | - |
| Government Pension Fund Global | 1.07 | 88544194 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sarandhar Singh* (please refer notes) | 20.66 | 88544153 | 0 | 0 |
| Basudeo Narain Singh | 7.27 | 88544154 | 0 | 0 |
| Mritunjay Kumar Singh | 6.42 | 88544155 | 0 | 0 |
| Madhurima Singh$ (please refer notes) | 5.39 | 88544156 | 0 | 0 |
| Madhurima Singh@ (please refer notes) | 2.59 | 88544157 | 0 | 0 |
| Jayanti Sinha | 2.46 | 88544158 | 0 | 0 |
| Seema Singh | 2.16 | 88544159 | 0 | 0 |
| Archana Singh | 2 | 88544160 | 0 | 0 |
| Aniruddha Singh& (please refer notes) | 1.01 | 88544161 | 0 | 0 |
| Divya Singh& (please refer notes) | 1.01 | 88544162 | 0 | 0 |
| Meghna Singh | 1.01 | 88544163 | 0 | 0 |
| Shrey Shree Anant Singh | 1 | 88544164 | 0 | 0 |
| Madhurima Singh& (please refer notes) | 0.79 | 88544165 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Icici Prudential India Opportunities Fund | 4.22 | 88544182 |
| Dsp Midcap Fund | 2.33 | 88544183 |
| Sbi Contra Fund | 1.59 | 88544184 |
| Nippon Life India Trustee Ltd-A/C Nippon India Growth Fund | 1.52 | 88544185 |
| Kotak Emerging Equity Scheme | 1.06 | 88544186 |
| Government Pension Fund Global | 1.07 | 88544194 |
| Hdfc Life Insurance Company Limited | 1.45 | 88544188 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Kishor Kumar Singh | 2.84 | 88544204 |
| Alok Kumar | 2.31 | 88544205 |
| Ashok Kumar | 2.26 | 88544206 |
| Deepak Kumar Singh | 2.15 | 88544207 |
| Rajesh Kumar | 1.41 | 88544208 |
| Rajeev Ranjan | 1.24 | 88544209 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 09, 2024 | 5 | FINAL | Aug 10, 2024 | Equity Share |
| Feb 16, 2024 | 35 | INTERIM | Feb 17, 2024 | Equity Share |
| Aug 10, 2023 | 10 | FINAL | Aug 10, 2023 | Equity Share |
| Feb 17, 2023 | 25 | SPECIAL | Feb 18, 2023 | Equity Share |
| Feb 17, 2023 | 15 | INTERIM | Feb 18, 2023 | Equity Share |
| Aug 08, 2022 | 4 | FINAL | Aug 10, 2022 | Equity Share |
| Feb 10, 2022 | 30 | INTERIM | Feb 12, 2022 | Equity Share |
| Aug 09, 2021 | 5 | FINAL | Aug 10, 2021 | Equity Share |
| Feb 11, 2021 | 25 | INTERIM | Feb 13, 2021 | Equity Share |
| Aug 10, 2020 | 3 | FINAL | Aug 11, 2020 | Equity Share |
| Feb 13, 2020 | 22 | INTERIM | Feb 15, 2020 | Equity Share |
| Aug 19, 2019 | 8 | FINAL | Aug 20, 2019 | Equity Share |
| Feb 15, 2019 | 8 | INTERIM | Feb 18, 2019 | Equity Share |
| Aug 23, 2018 | 7 | FINAL | Aug 24, 2018 | Equity Share |
| Feb 16, 2018 | 6 | INTERIM | Feb 20, 2018 | Equity Share |
| Aug 31, 2017 | 9 | FINAL | Sep 01, 2017 | Equity Share |
| Nov 23, 2016 | 6 | INTERIM | Nov 24, 2016 | Equity Share |
| Mar 18, 2016 | 9.7 | INTERIM | Mar 21, 2016 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Aug 09, 2024 | Quarterly Results | - |
| May 29, 2024 | Audited Results & Final Dividend | - |
| Feb 09, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 10, 2023 | Quarterly Results | - |
| May 19, 2023 | Audited Results & Final Dividend | - |
| Feb 10, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 05, 2022 | Quarterly Results | - |
| May 13, 2022 | Audited Results & Final Dividend | - |
| Feb 04, 2022 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 06, 2021 | Quarterly Results | - |
| May 25, 2021 | Audited Results & Final Dividend | - |
| Feb 05, 2021 | Quarterly Results & Interim Dividend | - |
| Nov 06, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| Jun 05, 2020 | Audited Results & Final Dividend | - |
| Feb 07, 2020 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results & Final Dividend | - |
| Feb 08, 2019 | Quarterly Results & Interim Dividend | - |
| Nov 02, 2018 | Quarterly Results | - |
| Aug 10, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results & Final Dividend | - |
| Feb 09, 2018 | Quarterly Results & Interim Dividend | - |
| Nov 10, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 26, 2017 | Audited Results & Final Dividend | - |
| Feb 10, 2017 | Quarterly Results | - |
| Nov 11, 2016 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 27, 2016 | Audited Results | - |
| Mar 09, 2016 | 2nd Interim Dividend | Approved the Option Agreement with Mr. Tushar Kumar for grant of Option to purchase the trust units held by the Company in Avenue Venture Real Estate Fund. |
| Feb 12, 2016 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
27 Jul 2024
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 read along with Schedule III os SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s newspapers viz Business Standard (English) and Mumbai Lakshadeep (Marathi) informing about completion of dispach of Notice of 50th AGM (including details of e-voting facility) along with Annual Report for financial year 2023-24 through electronic mode. The same is also available on the website of the Company. Kindly take the same on record.
26 Jul 2024
Alkem Laboratories Ltd - 539523 - Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to Regulation 34(2) of SEBI (LODR) Regulations, 2015, please find enclosed herewith the Business Responsibility and Sustainability Report for financial year ended 31st March, 2024. The same is also available on the website of the Company. Kindly take the same on record.
26 Jul 2024
Alkem Laboratories Ltd - 539523 - Reg. 34 (1) Annual Report.
Please find enclosed herewith the Notice of the 50th Annual General Meeting of the Company scheduled to be held on Friday, 30th August, 2024 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) alongwith the Annual Report for financial year 2023-2024. The same is also available on the website of the Company at www.alkemlabs.com Kindly take the same on record.
25 Jul 2024
Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Board Meeting Of Directors Of Alkem Laboratories Limited
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2024.
22 Jul 2024
Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
16 Jul 2024
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of SEBI LODR Regulations, we wish to inform you about the change in senior management personnel of the Company.
16 Jul 2024
Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
15 Jul 2024
Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Incorporation Of A Wholly Owned Subsidiary Of The Company
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Wholly Owned Subsidiary of the Company in the name of "Alixer Nexgen Therapeutics Limited" has been incorporated on 12th July, 2024.
12 Jul 2024
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 read alonwith Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 50th Annual General Meeting of the Company to be held through video conferencing (VC) and other audio visual means (OAVM). The same is also available on the website of the Company. Kindly take the same on record.
11 Jul 2024
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi). The copy of the aforesaid newspaper advertisement is also available on the website of the Company. Kindly take the same on record.
